REPL
Replimune Group, Inc.
NASDAQ · Healthcare · Biotechnology · US
$15.04
−1.64%Leverage
- Debt / equity
- 1.06x
- Net debt / equity
- -0.69x
- Debt / assets
- 0.44x
- Debt / EBITDA
- -0.38x
- Net debt / EBITDA
- 0.25x
Liquidity & coverage
- Current ratio
- 5.23x
- Quick ratio
- 5.23x
- Cash ratio
- 5.09x
- Interest coverage
- -31.46x
- EBITDA / interest
- -30.76x
- Working capital
- $162.4M
Cash & dividend
- FCF / debt
- -2.51x
- Cash flow / debt
- -2.49x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026